A comparison of the tumour concentrations obtainable with misonidazole and Ro 03–8799
- 1 September 1986
- journal article
- research article
- Published by Oxford University Press (OUP) in The British Journal of Radiology
- Vol. 59 (705) , 911-917
- https://doi.org/10.1259/0007-1285-59-705-911
Abstract
Both Ro 03-8799 and misonidazole were administered to six patients before tumour sampling. Using similar doses, tumour concentrations of Ro 03-8799 were approximately double those of misonidazole. Examination of the data with regard to the relative sensitising efficiencies of these two compounds gives us, as a conservative estimate, a factor of 1.6 in favour of Ro 03-8799. From these observations it is predicted that, when given with radiotherapy in a 25-fraction course Ro 03-8799, is likely to be at least five times more effective as a hypoxic cell sensitiser than misonidazole.This publication has 7 references indexed in Scilit:
- Cellular Uptake of Misonidazole and Analogues with Acidic or Basic FunctionsInternational Journal of Radiation Biology, 1985
- The concentration of desmethylmisonidazole in human tumours and in cerebrospinal fluidBritish Journal of Cancer, 1981
- Structure-activity Relationships in the Development of Hypoxic Cell RadiosensitizersInternational Journal of Radiation Biology, 1979
- Clinical testing of the radiosensitizer Ro 07-0582: Experience with multiple dosesBritish Journal of Cancer, 1977
- Electron-Affinic Sensitization: VII. A Correlation between Structures, One-Electron Reduction Potentials, and Efficiencies of Nitroimidazoles as Hypoxic Cell RadiosensitizersRadiation Research, 1976